Pola Peresepan Obat Pasien Gagal Jantung Kongestif RSUP Dr. Hasan Sadikin Bandung

Authors

  • Muhammad Ilham Al Ghifari Prodi Farmasi, Fakultas Farmasi dan Sains, Universitas Islam Bandung, Indonesia
  • Bambang Tri Laksono Prodi Farmasi, Fakultas Farmasi dan Sains, Universitas Islam Bandung, Indonesia
  • Andrian Hoerul Anwar Prodi Farmasi, Fakultas Farmasi dan Sains, Universitas Islam Bandung, Indonesia

DOI:

https://doi.org/10.29313/bcsp.v6i2.24807

Keywords:

Gagal Jantung Kongesti, Pola Peresepan, Rawat Jalan

Abstract

Abstract. Heart failure is a leading cause of global morbidity and mortality, presenting a significant burden on healthcare systems. The complexity of pharmacological therapy for chronic heart failure requires systematic evaluation to ensure clinical effectiveness and medication adherence. This study aims to evaluate the prescribing patterns of primary and adjunctive drugs based on demographic characteristics in congestive heart failure patients at Dr. Hasan Sadikin General Hospital Bandung in the 2025 period. This research is a descriptive observational study with a retrospective cross-sectional design. Samples were obtained through a total sampling technique from the medical records of outpatient cases (ICD-10: 150.0) for the January-December 2025 period. Out of 258 samples, patients were predominantly male (60.85%) and aged 45-64 years (55.04%). The primary heart failure drug prescribing pattern was dominated by diuretics (36.83%) and beta-blockers (25.93%), with the main active ingredients being spironolactone, furosemide, and bisoprolol. Meanwhile, the adjunctive drug prescribing pattern was mostly dominated by antiplatelets (30.84%), statin antidyslipidemics (27.44%), and PPI gastroprotectors (14.12%).

Abstrak. Gagal jantung merupakan salah satu penyebab utama morbiditas dan mortalitas global yang memberikan beban signifikan pada sistem pelayanan kesehatan. Kompleksitas terapi farmakologis untuk gagal jantung kronis memerlukan evaluasi sistematis untuk memastikan efektivitas klinis dan kepatuhan pengobatan. Penelitian ini bertujuan mengevaluasi pola peresepan obat utama dan obat penunjang berdasarkan karakteristik demografi pada pasien gagal jantung kongestif di RSUP dr. Hasan Sadikin Bandung periode 2025. Penelitian ini merupakan studi observasional deskriptif dengan desain cross-sectional retrospektif. Sampel diambil melalui teknik total sampling dari rekam medis pasien rawat jalan (ICD-10: 150.0) periode Januari hingga Desember 2025. Dari 258 sampel, pasien paling banyak adalah laki-laki (60,85%) dan kelompok usia 45–64 tahun (55,04%). Pola peresepan obat gagal jantung utama didominasi golongan diuretik (36,83%) dan beta bloker (25,93%), dengan zat aktif utama spironolakton, furosemide, dan bisoprolol. Sementara itu, pola peresepan obat penunjang terbanyak didominasi oleh golongan antiplatelet (30,84%), antidislipidemia statin (27,44%), dan gastroprotektor PPI (14,12%). 

References

Atherton, J. J., Sindone, A., De Pasquale, C. G., Driscoll, A., MacDonald, P. S., Hopper, I., Kistler, P. M., Briffa, T., Wong, J., Abhayaratna, W., Thomas, L., Audehm, R., Newton, P., O’Loughlin, J., Branagan, M., & Connell, C. (2018). National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018. Heart Lung and Circulation, 27(10), 1123–1208. https://doi.org/10.1016/j.hlc.2018.06.1042

DiPiro, J. T., Yee, G. C., Haines, S. T., Nolin, T. D., Ellingrod, V. L., & Posey, L. M. (2023). DiPiro’s Pharmacotherapy a Pathophysiologic Approach 12th Edition.

Emmons-Bell, S., Johnson, C., & Roth, G. (2022). Prevalence, incidence and survival of heart failure: a systematic review. In Heart (Vol. 108, Number 17, pp. 1351–1360). BMJ Publishing Group. https://doi.org/10.1136/heartjnl-2021-320131

Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., Fang, J. C., Fedson, S. E., Fonarow, G. C., Hayek, S. S., Hernandez, A. F., Khazanie, P., Kittleson, M. M., Lee, C. S., Link, M. S., … Yancy, C. W. (2022a). 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. In Circulation (Vol. 145, Number 18, pp. E895–E1032). Lippincott Williams and Wilkins. https://doi.org/10.1161/CIR.0000000000001063

Katzung, B. G. (2018). Basic & clinical pharmacology. McGraw-Hill.

Kemenkes. (2021). Pedoman Nasional Pelayanan Kedokteran Tata Laksana Gagal Jantung.

Kemenkes. (2023). Survei Kesehatan Indonesia. Kementerian Kesehatan Republik Indonesia.

Mardhiah, A., Ika Savitri, D., & Rahayu Fonna, T. (2023). Congestive Heart Failure. GALENICAL: Jurnal Kedokteran dan Kesehatan Mahasiswa Malikussaleh, 2(3).

McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Celutkiene, J., Chioncel, O., Cleland, J. G. F., Crespo-Leiro, M. G., Farmakis, D., Gilard, M., Heymans, S., Hoes, A. W., Jaarsma, T., Jankowska, E. A., Lainscak, M., … Zeppenfeld, K. (2023). 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal, 44(37), 3627–3639. https://doi.org/10.1093/eurheartj/ehad195

PERKI. (2023). Pedoman Tatalaksana Gagal Jantung (Edisi Ketiga). Perhimpunan Dokter Spesialis Kardiovaskular Indonesia.

Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V. P., Jankowska, E. A., Jessup, M., Linde, C., Nihoyannopoulos, P., Parissis, J. T., Pieske, B., Riley, J. P., Rosano, G. M. C., Ruilope, L. M., Ruschitzka, F., … Davies, C. (2016). 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. In European Heart Journal (Vol. 37, Number 27, pp. 2129–2200m). Oxford University Press. https://doi.org/10.1093/eurheartj/ehw128

Savarese, G., Becher, P. M., Lund, L. H., Seferovic, P., Rosano, G. M. C., & Coats, A. J. S. (2022). Global burden of heart failure: a comprehensive and updated review of epidemiology. In Cardiovascular Research (Vol. 118, Number 17, pp. 3272–3287). Oxford University Press. https://doi.org/10.1093/cvr/cvac013

Yandrapalli, S., Khan, M. H., Rochlani, Y., & Aronow, W. S. (2018). Sacubitril/valsartan in cardiovascular disease: evidence to date and place in therapy. In Therapeutic Advances in Cardiovascular Disease (Vol. 12, Number 8, pp. 217–231). SAGE Publications Ltd. https://doi.org/10.1177/1753944718784536

Yunita, N. L. P. N. (2021). Pola Penggunaan Obat Pada Pasien Gagal Jantung Rawat Jalan di Salah Satu Rumah Sakit Swasta di Bali. JIM: Jurnal Ilmiah Mahaganesha. https://farmasimahaganesha.ac.id

Published

2026-08-01

Issue

Vol. 6 No. 2 (2026): Bandung Conference Series: Pharmacy

Section

Articles